Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes

Aims/hypothesis Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3...

Full description

Saved in:

Bibliographic Details
Published in:	Diabetologia Vol. 61; no. 2; pp. 399 - 412
Main Authors:	Szpigel, Anaïs, Hainault, Isabelle, Carlier, Aurélie, Venteclef, Nicolas, Batto, Anne-Françoise, Hajduch, Eric, Bernard, Catherine, Ktorza, Alain, Gautier, Jean-François, Ferré, Pascal, Bourron, Olivier, Foufelle, Fabienne
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2018 Springer Nature B.V Springer Verlag
Subjects:	Body fat Carbohydrates Cellular Biology Ceramide Chemokines Cytokines Desaturase Diabetes Diabetes mellitus Endocrinology Endoplasmic reticulum Enzymes Ethics Glucose Human Physiology IL-1β Inflammasomes Inflammation Insulin Insulin resistance Internal Medicine Kinases Leukocytes (mononuclear) Life Sciences Ligands Lipid metabolism Lipids Macrophages Medicine Medicine & Public Health Metabolic Diseases Monocytes Palmitic acid Peripheral blood mononuclear cells Plasma Protein folding Proteins Pyrin protein Reverse transcription Sphingomyelin Thioredoxin Transcription factors Diabetes mellitus Ceramide Peripheral blood mononuclear cells NLRP3 TXNIP Inflammasome Sphingolipids Macrophages Endoplasmic reticulum stress
ISSN:	0012-186X, 1432-0428, 1432-0428
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Aims/hypothesis Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation. Methods The expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells. Results The expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β. Conclusions/interpretation In individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes.
AbstractList	Aims/hypothesisObesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation.MethodsThe expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells.ResultsThe expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β.Conclusions/interpretationIn individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes. Aims/hypothesis Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation. Methods The expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells. Results The expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β. Conclusions/interpretation In individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes. Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation.AIMS/HYPOTHESISObesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation.The expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells.METHODSThe expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells.The expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β.RESULTSThe expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β.In individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes.CONCLUSIONS/INTERPRETATIONIn individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes. Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin interacting protein (TXNIP) has been implicated in the activation process of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we aim to determine whether the expression of TXNIP is altered in the circulating immune cells of individuals with type 2 vs type 1 diabetes and whether this can be related to specific causes and consequences of inflammation. The expression of TXNIP, inflammatory markers, markers of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress and enzymes involved in sphingolipid metabolism was quantified by quantitative reverse transcription real-time PCR (qRT-PCR) in peripheral blood mononuclear cells (PBMCs) of 13 non-diabetic individuals, 23 individuals with type 1 diabetes and 81 with type 2 diabetes. A lipidomic analysis on the plasma of 13 non-diabetic individuals, 35 individuals with type 1 diabetes and 94 with type 2 diabetes was performed. The effects of ER stress or of specific lipids on TXNIP and inflammatory marker expression were analysed in human monocyte-derived macrophages (HMDMs) and THP-1 cells. The expression of TXNIP and inflammatory and UPR markers was increased in the PBMCs of individuals with type 2 diabetes when compared with non-diabetic individuals or individuals with type 1 diabetes. TXNIP expression was significantly correlated with plasma fasting glucose, plasma triacylglycerol concentrations and specific UPR markers. Induction of ER stress in THP-1 cells or cultured HMDMs led to increased expression of UPR markers, TXNIP, NLRP3 and IL-1β. Conversely, a chemical chaperone reduced the expression of UPR markers and TXNIP in PBMCs of individuals with type 2 diabetes. The lipidomic plasma analysis revealed an increased concentration of saturated dihydroceramide and sphingomyelin in individuals with type 2 diabetes when compared with non-diabetic individuals and individuals with type 1 diabetes. In addition, the expression of specific enzymes of sphingolipid metabolism, dihydroceramide desaturase 1 and sphingomyelin synthase 1, was increased in the PBMCs of individuals with type 2 diabetes. Palmitate or C2 ceramide induced ER stress in macrophages as well as increased expression of TXNIP, NLRP3 and IL-1β. In individuals with type 2 diabetes, circulating immune cells display an inflammatory phenotype that can be linked to ER stress and TXNIP expression. Immune cell ER stress can in turn be linked to the specific exogenous and endogenous lipid environment found in type 2 diabetes.
Author	Batto, Anne-Françoise Ferré, Pascal Hainault, Isabelle Bernard, Catherine Foufelle, Fabienne Carlier, Aurélie Ktorza, Alain Bourron, Olivier Venteclef, Nicolas Szpigel, Anaïs Hajduch, Eric Gautier, Jean-François
Author_xml	– sequence: 1 givenname: Anaïs surname: Szpigel fullname: Szpigel, Anaïs organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Institut de Recherches Servier – sequence: 2 givenname: Isabelle surname: Hainault fullname: Hainault, Isabelle organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers – sequence: 3 givenname: Aurélie surname: Carlier fullname: Carlier, Aurélie organization: Department of Endocrinology, Nutrition, and Diabetes, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris – sequence: 4 givenname: Nicolas surname: Venteclef fullname: Venteclef, Nicolas organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers – sequence: 5 givenname: Anne-Françoise surname: Batto fullname: Batto, Anne-Françoise organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers – sequence: 6 givenname: Eric surname: Hajduch fullname: Hajduch, Eric organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers – sequence: 7 givenname: Catherine surname: Bernard fullname: Bernard, Catherine organization: Institut de Recherches Servier – sequence: 8 givenname: Alain surname: Ktorza fullname: Ktorza, Alain organization: Institut de Recherches Servier – sequence: 9 givenname: Jean-François surname: Gautier fullname: Gautier, Jean-François organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Department of Diabetes and Endocrinology, Lariboisière Hospital, DHU FIRE, Assistance Publique-Hôpitaux de Paris – sequence: 10 givenname: Pascal surname: Ferré fullname: Ferré, Pascal organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Department of Oncology and Endocrine Biochemistry, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris – sequence: 11 givenname: Olivier surname: Bourron fullname: Bourron, Olivier organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Department of Endocrinology, Nutrition, and Diabetes, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris – sequence: 12 givenname: Fabienne surname: Foufelle fullname: Foufelle, Fabienne email: fabienne.foufelle@crc.jussieu.fr organization: Inserm, UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28988346$$D View this record in MEDLINE/PubMed https://hal.science/hal-02450833$$DView record in HAL
BookMark	eNp9kVFr1TAUx4NsuLvpB_BFAr5MWDVJkyZ9HGNug4uKTNhbyG1OXUab1iS9un36pesmMlAIhHPO739OTv77aMcPHhB6Q8kHSoj8GAmhTBSEyoLzihXiBVpRXrKCcKZ20GouF1RVV3toP8YbQkgpePUS7TFVK1XyaoXu1m50FoPfujD4HnzCztupgYhPv-GYAsR4hC-vPl98xfB7nEM3eGy8zVzbmb43aU64fPp-8oAb6LqIh3bu47bOTiaHv1y6xul2BMywdWYDCeIrtNvmGrx-vA_Q90-nlyfnxfrL2cXJ8bpoOK9TQcHW0IKsjZH1pqrqqlUglDJWEios21DRtMrIxlrgllTQmFZYYSxpjATGygP0ful7bTo9BtebcKsH4_T58VrPOcK4IKostzSzhws7huHnBDHp3sV5I-NhmKKmNa-JEiWXGX33DL0ZpuDzJplSjEpBJMnU20dq2vRg_8x_ciADcgGaMMQYoNWNSw9_moJxnaZEz17rxWudvdaz11pkJX2mfGr-Pw1bNDGz_geEvx79T9E9vwa7hQ
CitedBy_id	crossref_primary_10_1038_s41598_024_54559_y crossref_primary_10_1155_2021_1805147 crossref_primary_10_1038_s41467_020_19554_7 crossref_primary_10_3390_jcm8091322 crossref_primary_10_3390_nu17152546 crossref_primary_10_3390_ijms19123977 crossref_primary_10_1002_jcp_30627 crossref_primary_10_1016_j_jlr_2022_100270 crossref_primary_10_1016_j_bbamcr_2021_119001 crossref_primary_10_1016_j_expneurol_2025_115304 crossref_primary_10_3390_ijms241914585 crossref_primary_10_1002_oby_24156 crossref_primary_10_1007_s11655_023_3598_z crossref_primary_10_1016_j_bbrc_2019_07_074 crossref_primary_10_14814_phy2_13926 crossref_primary_10_1016_j_bbalip_2021_158964 crossref_primary_10_1016_j_bbrc_2018_05_185 crossref_primary_10_1016_j_diabres_2021_108699 crossref_primary_10_1186_s12933_023_01845_0 crossref_primary_10_3389_fphar_2019_01230 crossref_primary_10_1186_s12974_022_02598_5 crossref_primary_10_3390_biomedicines8070210 crossref_primary_10_1038_s41416_023_02442_4 crossref_primary_10_1016_j_numecd_2020_08_006 crossref_primary_10_1016_j_bcp_2018_04_026 crossref_primary_10_1016_j_freeradbiomed_2021_07_015 crossref_primary_10_1016_j_bbalip_2019_06_002 crossref_primary_10_2147_JIR_S402592 crossref_primary_10_1186_s12902_024_01679_1 crossref_primary_10_3389_fphar_2020_00727 crossref_primary_10_1002_ejlt_202200172 crossref_primary_10_1016_j_ab_2022_114982 crossref_primary_10_1002_mnfr_70218 crossref_primary_10_1111_jdi_13338 crossref_primary_10_3390_ijms231810632 crossref_primary_10_1038_s41598_024_70477_5 crossref_primary_10_1111_jcmm_15045 crossref_primary_10_3390_ijms20030479 crossref_primary_10_1002_cbin_11350 crossref_primary_10_31083_j_fbl2808159 crossref_primary_10_3390_ijms22041693 crossref_primary_10_3390_jcm10040792 crossref_primary_10_2478_enr_2025_0008 crossref_primary_10_1016_j_phrs_2023_106983 crossref_primary_10_1017_thg_2021_42 crossref_primary_10_1002_fsn3_1407 crossref_primary_10_3389_fimmu_2021_692004 crossref_primary_10_4049_jimmunol_1801550 crossref_primary_10_1142_S0192415X20500706 crossref_primary_10_3389_fendo_2020_00491 crossref_primary_10_1007_s00018_018_2984_8 crossref_primary_10_1016_j_lfs_2019_117138 crossref_primary_10_1038_s41598_022_08791_z crossref_primary_10_1016_j_it_2021_07_005 crossref_primary_10_5812_mejrh_129041 crossref_primary_10_3389_fimmu_2019_02756 crossref_primary_10_1177_03000605221111275 crossref_primary_10_3389_fmolb_2019_00147 crossref_primary_10_1007_s12633_019_0085_4 crossref_primary_10_1016_j_tem_2018_04_008 crossref_primary_10_2147_JIR_S396604 crossref_primary_10_1016_j_jep_2019_111904 crossref_primary_10_3389_fimmu_2023_1099459 crossref_primary_10_1016_j_cellsig_2025_111702 crossref_primary_10_1007_s12192_018_0936_8 crossref_primary_10_1007_s11596_023_2781_y crossref_primary_10_1111_obr_13045 crossref_primary_10_1155_2023_9563359 crossref_primary_10_3390_metabo11120807 crossref_primary_10_1007_s00011_019_01273_5 crossref_primary_10_2147_IJGM_S343727 crossref_primary_10_3390_cancers12103028 crossref_primary_10_1007_s11033_025_10946_w crossref_primary_10_3389_fimmu_2023_1082050 crossref_primary_10_1016_j_micpath_2020_104645 crossref_primary_10_1039_C8FO01026A crossref_primary_10_2147_DMSO_S349153 crossref_primary_10_1007_s10495_023_01854_0 crossref_primary_10_2147_JIR_S426439 crossref_primary_10_1016_j_jpba_2022_114590 crossref_primary_10_1016_j_metabol_2020_154404 crossref_primary_10_1007_s10753_023_01958_4 crossref_primary_10_1016_j_neubiorev_2022_104818 crossref_primary_10_1016_j_bcp_2024_116436 crossref_primary_10_1155_2019_9846325 crossref_primary_10_3390_cells8121633 crossref_primary_10_1007_s40200_023_01270_w crossref_primary_10_1016_j_mce_2023_111885 crossref_primary_10_1039_C9FO02602A crossref_primary_10_1016_j_xcrm_2025_102050 crossref_primary_10_1089_ars_2022_0022 crossref_primary_10_4239_wjd_v16_i9_110515 crossref_primary_10_1016_j_mce_2023_112012 crossref_primary_10_3390_biomedicines9020156 crossref_primary_10_3390_ijms23168851
Cites_doi	10.1126/science.1128294 10.1074/jbc.M110.186916 10.1128/MCB.23.21.7448-7459.2003 10.1016/j.immuni.2015.08.008 10.1089/ars.2014.5868 10.3892/mmr.2013.1582 10.1002/oby.20598 10.1038/ni.1831 10.1242/jcs.026062 10.1161/ATVBAHA.112.251538 10.2337/db06-1650 10.1016/j.cmet.2012.07.005 10.1038/nm.2279 10.1074/jbc.M115.686949 10.1007/s00125-009-1274-2 10.1007/s00125-011-2328-9 10.1128/MCB.21.9.3220-3233.2001 10.1016/j.atherosclerosis.2015.11.015 10.1016/j.celrep.2016.02.053 10.1189/jlb.3A1214-609R 10.1007/s00125-006-0590-z 10.1016/j.cell.2010.02.034 10.1016/j.cmet.2012.04.002 10.1210/me.2014-1095 10.1074/jbc.M411860200 10.1016/j.cmet.2012.07.007 10.1074/jbc.274.31.21645 10.1038/nm.2067 10.1210/jc.2006-1518 10.1074/jbc.M111.287383 10.2337/db12-0686 10.1038/ncb1035 10.1016/S0092-8674(01)00611-0 10.1210/en.2004-0478 10.1073/pnas.0712199105 10.4049/jimmunol.1402655 10.1172/JCI37007 10.1074/jbc.M115.709626 10.1074/jbc.M110.170621 10.1038/nri2925 10.1016/j.tibs.2016.09.002 10.1172/JCI25102 10.1038/nm.2627 10.1371/journal.pmed.0040158
ContentType	Journal Article
Copyright	Springer-Verlag GmbH Germany 2017 Diabetologia is a copyright of Springer, (2017). All Rights Reserved. Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml	– notice: Springer-Verlag GmbH Germany 2017 – notice: Diabetologia is a copyright of Springer, (2017). All Rights Reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID	AAYXX CITATION NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC
DOI	10.1007/s00125-017-4462-5
DatabaseName	CrossRef PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL)
DatabaseTitle	CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest One Academic Middle East (New) MEDLINE - Academic PubMed
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1432-0428
EndPage	412
ExternalDocumentID	oai:HAL:hal-02450833v1 28988346 10_1007_s00125_017_4462_5
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: Fondation pour la Recherche Médicale grantid: Equipe FRM DEQ20140329504 funderid: http://dx.doi.org/10.13039/501100002915 – fundername: Fondation pour la Recherche Médicale grantid: Equipe FRM DEQ20140329504
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1CY 1N0 1SB 2.D 203 28- 29F 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAEWM AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- MVM N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P6G P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS R4E R89 R9I RHV RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TR2 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z7W Z82 Z83 Z87 Z8O Z8P Z8Q Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY NPM 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 ESTFP PUEGO 1XC
ID	FETCH-LOGICAL-c449t-1ed9efe79aa79b6696f8e588ad7015d2b15cf8a7cdde4d06ecaf5d5ad0ca7e223
IEDL.DBID	8C1
ISICitedReferencesCount	110
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000419011600015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0012-186X 1432-0428
IngestDate	Tue Oct 14 20:27:16 EDT 2025 Mon Sep 08 12:48:01 EDT 2025 Thu Nov 27 13:41:48 EST 2025 Wed Feb 19 02:44:38 EST 2025 Sat Nov 29 02:07:39 EST 2025 Tue Nov 18 22:43:10 EST 2025 Fri Feb 21 02:35:32 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	Diabetes mellitus Ceramide Peripheral blood mononuclear cells NLRP3 TXNIP Inflammasome Sphingolipids Macrophages Endoplasmic reticulum stress
Language	English
License	Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c449t-1ed9efe79aa79b6696f8e588ad7015d2b15cf8a7cdde4d06ecaf5d5ad0ca7e223
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-0125-7751 0000-0003-0115-7045 0000-0002-0752-622X
OpenAccessLink	https://link.springer.com/content/pdf/10.1007/s00125-017-4462-5.pdf
PMID	28988346
PQID	1982175070
PQPubID	48469
PageCount	14
ParticipantIDs	hal_primary_oai_HAL_hal_02450833v1 proquest_miscellaneous_1949085347 proquest_journals_1982175070 pubmed_primary_28988346 crossref_citationtrail_10_1007_s00125_017_4462_5 crossref_primary_10_1007_s00125_017_4462_5 springer_journals_10_1007_s00125_017_4462_5
PublicationCentury	2000
PublicationDate	20180200 2018-2-00 2018-02-00 20180201 2018-02
PublicationDateYYYYMMDD	2018-02-01
PublicationDate_xml	– month: 2 year: 2018 text: 20180200
PublicationDecade	2010
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany – name: Heidelberg
PublicationSubtitle	Clinical, Translational and Experimental Diabetes and Metabolism
PublicationTitle	Diabetologia
PublicationTitleAbbrev	Diabetologia
PublicationTitleAlternate	Diabetologia
PublicationYear	2018
Publisher	Springer Berlin Heidelberg Springer Nature B.V Springer Verlag
Publisher_xml	– name: Springer Berlin Heidelberg – name: Springer Nature B.V – name: Springer Verlag
References	Vandanmagsar, Youm, Ravussin (CR21) 2011; 17 Serlie, Meijer, Groener, Ackermans, Aerts, Sauerwein (CR43) 2007; 92 Erbay, Babaev, Mayers (CR33) 2009; 15 Tran, Postal, Demignot (CR13) 2016; 291 Ozcan, Yilmaz, Ozcan (CR30) 2006; 313 Lenin, Sankaramoorthy, Mohan, Balasubramanyam (CR35) 2015; 98 Zhang, Zhang, Chen (CR37) 2015; 22 Osborn, Olefsky (CR1) 2012; 18 Boon, Hoy, Stark (CR24) 2013; 62 Lee, Iwakoshi, Glimcher (CR18) 2003; 23 Hage Hassan, Pacheco de Sousa, Mahfouz (CR22) 2016; 291 Nishiyama, Matsui, Iwata (CR9) 1999; 274 Donath, Shoelson (CR3) 2011; 11 Devevre, Renovato-Martins, Clement, Sautes-Fridman, Cremer, Poitou (CR2) 2015; 194 Cunha, Hekerman, Ladriere (CR27) 2008; 121 Ehses, Perren, Eppler (CR4) 2007; 56 He, Hara, Nunez (CR5) 2016; 41 Rocha, Caldas, Oliveira, Bressan, Hermsdorff (CR40) 2016; 244 Mamtani, Meikle, Kulkarni (CR45) 2014; 22 Zhou, Tardivel, Thorens, Choi, Tschopp (CR8) 2010; 11 Parker, Phan, Baumeister (CR19) 2001; 21 Nakatani, Kaneto, Kawamori (CR29) 2005; 280 Svoboda, Tastenoy, Zhang (CR17) 2013; 8 Robblee, Kim, Abate (CR34) 2016; 14 Chavez, Summers (CR42) 2012; 15 Oslowski, Hara, OʼSullivan-Murphy (CR7) 2012; 16 Hu, Ross, Geng, Brice, Cowart (CR39) 2011; 286 Sims, Haynes, Kelly (CR41) 2010; 285 Yoshida, Matsui, Yamamoto, Okada, Mori (CR20) 2001; 107 Wellen, Hotamisligil (CR25) 2005; 115 Laybutt, Preston, Akerfeldt (CR26) 2007; 50 Li, Fan, Liu (CR38) 2012; 32 Shalev (CR10) 2014; 28 Feng, Yao, Li (CR32) 2003; 5 Bronner, Abuaita, Chen (CR36) 2015; 43 Bellis, Kulkarni, Mamtani (CR44) 2014; 7 Parikh, Carlsson, Chutkow (CR14) 2007; 4 Hage Hassan, Hainault, Vilquin (CR12) 2012; 55 Senkal, Ponnusamy, Manevich (CR23) 2011; 286 Kharroubi, Ladriere, Cardozo, Dogusan, Cnop, Eizirik (CR28) 2004; 145 Hotamisligil (CR31) 2010; 140 Lerner, Upton, Praveen (CR6) 2012; 16 Shaked, Ketzinel-Gilad, Ariav, Cerasi, Kaiser, Leibowitz (CR15) 2009; 52 Kammoun, Chabanon, Hainault (CR11) 2009; 119 Stoltzman, Peterson, Breen, Muoio, Billin, Ayer (CR16) 2008; 105 M Shaked (4462_CR15) 2009; 52 MM Robblee (4462_CR34) 2016; 14 EF Devevre (4462_CR2) 2015; 194 DN Bronner (4462_CR36) 2015; 43 M Svoboda (4462_CR17) 2013; 8 DA Cunha (4462_CR27) 2008; 121 K Sims (4462_CR41) 2010; 285 MY Donath (4462_CR3) 2011; 11 R Parker (4462_CR19) 2001; 21 KE Wellen (4462_CR25) 2005; 115 Y Nakatani (4462_CR29) 2005; 280 B Vandanmagsar (4462_CR21) 2011; 17 C Bellis (4462_CR44) 2014; 7 GS Hotamisligil (4462_CR31) 2010; 140 TTT Tran (4462_CR13) 2016; 291 JA Chavez (4462_CR42) 2012; 15 I Kharroubi (4462_CR28) 2004; 145 A Nishiyama (4462_CR9) 1999; 274 DM Rocha (4462_CR40) 2016; 244 DR Laybutt (4462_CR26) 2007; 50 ZQ Li (4462_CR38) 2012; 32 R Hage Hassan (4462_CR12) 2012; 55 J Boon (4462_CR24) 2013; 62 O Osborn (4462_CR1) 2012; 18 H Parikh (4462_CR14) 2007; 4 R Lenin (4462_CR35) 2015; 98 A Shalev (4462_CR10) 2014; 28 JA Ehses (4462_CR4) 2007; 56 B Feng (4462_CR32) 2003; 5 X Zhang (4462_CR37) 2015; 22 AG Lerner (4462_CR6) 2012; 16 M Mamtani (4462_CR45) 2014; 22 U Ozcan (4462_CR30) 2006; 313 CE Senkal (4462_CR23) 2011; 286 H Yoshida (4462_CR20) 2001; 107 CM Oslowski (4462_CR7) 2012; 16 W Hu (4462_CR39) 2011; 286 CA Stoltzman (4462_CR16) 2008; 105 R Hage Hassan (4462_CR22) 2016; 291 Y He (4462_CR5) 2016; 41 MJ Serlie (4462_CR43) 2007; 92 RB Zhou (4462_CR8) 2010; 11 HL Kammoun (4462_CR11) 2009; 119 AH Lee (4462_CR18) 2003; 23 E Erbay (4462_CR33) 2009; 15 25786686 - J Immunol. 2015 Apr 15;194(8):3917-23 22560211 - Cell Metab. 2012 May 2;15(5):585-94 23846350 - Mol Med Rep. 2013 Sep;8(3):829-36 18559892 - J Cell Sci. 2008 Jul 15;121(Pt 14):2308-18 15864338 - J Clin Invest. 2005 May;115(5):1111-9 20876532 - J Biol Chem. 2010 Dec 3;285(49):38568-79 25602171 - Antioxid Redox Signal. 2015 Apr 1;22(10 ):848-70 10419473 - J Biol Chem. 1999 Jul 30;274(31):21645-50 25363705 - Circ Cardiovasc Genet. 2014 Dec;7(6):854-863 27255710 - J Biol Chem. 2016 Jul 29;291(31):16328-38 23139352 - Diabetes. 2013 Feb;62(2):401-10 27669650 - Trends Biochem Sci. 2016 Dec;41(12 ):1012-1021 11287625 - Mol Cell Biol. 2001 May;21(9):3220-33 21217695 - Nat Med. 2011 Feb;17 (2):179-88 18458340 - Proc Natl Acad Sci U S A. 2008 May 13;105(19):6912-7 22006247 - Diabetologia. 2012 Jan;55(1):204-14 12907943 - Nat Cell Biol. 2003 Sep;5(9):781-92 19363290 - J Clin Invest. 2009 May;119(5):1201-15 11779464 - Cell. 2001 Dec 28;107(7):881-91 26123743 - J Leukoc Biol. 2015 Oct;98(4):615-22 15297438 - Endocrinology. 2004 Nov;145(11):5087-96 17472435 - PLoS Med. 2007 May;4(5):e158 21454530 - J Biol Chem. 2011 May 13;286(19):16596-605 20303879 - Cell. 2010 Mar 19;140(6):900-17 23929697 - Obesity (Silver Spring). 2014 Mar;22(3):950-6 22013072 - J Biol Chem. 2011 Dec 9;286(49):42446-58 26971994 - Cell Rep. 2016 Mar 22;14 (11):2611-23 20023662 - Nat Immunol. 2010 Feb;11(2):136-40 22883233 - Cell Metab. 2012 Aug 8;16(2):250-64 19966778 - Nat Med. 2009 Dec;15(12):1383-91 17062758 - J Clin Endocrinol Metab. 2007 Jan;92(1):166-71 22395709 - Nat Med. 2012 Mar 06;18(3):363-74 26341399 - Immunity. 2015 Sep 15;43(3):451-62 22580896 - Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1577-84 24911120 - Mol Endocrinol. 2014 Aug;28(8):1211-20 15509553 - J Biol Chem. 2005 Jan 7;280(1):847-51 14559994 - Mol Cell Biol. 2003 Nov;23 (21):7448-59 16931765 - Science. 2006 Aug 25;313(5790):1137-40 22883234 - Cell Metab. 2012 Aug 8;16(2):265-73 19214472 - Diabetologia. 2009 Apr;52(4):636-44 26698173 - J Biol Chem. 2016 Feb 5;291(6):3019-29 21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107 17268797 - Diabetologia. 2007 Apr;50(4):752-63 17579207 - Diabetes. 2007 Sep;56(9):2356-70 26687466 - Atherosclerosis. 2016 Jan;244:211-5
References_xml	– volume: 313 start-page: 1137 year: 2006 end-page: 1140 ident: CR30 article-title: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes publication-title: Science doi: 10.1126/science.1128294 – volume: 286 start-page: 16596 year: 2011 end-page: 16605 ident: CR39 article-title: Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance publication-title: J Biol Chem doi: 10.1074/jbc.M110.186916 – volume: 23 start-page: 7448 year: 2003 end-page: 7459 ident: CR18 article-title: XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response publication-title: Mol Cell Biol doi: 10.1128/MCB.23.21.7448-7459.2003 – volume: 43 start-page: 451 year: 2015 end-page: 462 ident: CR36 article-title: Endoplasmic reticulum stress activates the inflammasome via NLRP3-and caspase-2-driven mitochondrial damage publication-title: Immunity doi: 10.1016/j.immuni.2015.08.008 – volume: 22 start-page: 848 year: 2015 end-page: 870 ident: CR37 article-title: Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation publication-title: Antioxid Redox Signal doi: 10.1089/ars.2014.5868 – volume: 8 start-page: 829 year: 2013 end-page: 836 ident: CR17 article-title: D-glucose- and 3-O-methyl-D-glucose-induced upregulation of selected genes in rat hepatocytes and INS1E cells: re-evaluation of the possible role of hexose phosphorylation publication-title: Mol Med Rep doi: 10.3892/mmr.2013.1582 – volume: 22 start-page: 950 year: 2014 end-page: 956 ident: CR45 article-title: Plasma dihydroceramide species associate with waist circumference in Mexican American families publication-title: Obesity doi: 10.1002/oby.20598 – volume: 11 start-page: 136 year: 2010 end-page: 140 ident: CR8 article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation publication-title: Nat Immunol doi: 10.1038/ni.1831 – volume: 121 start-page: 2308 year: 2008 end-page: 2318 ident: CR27 article-title: Initiation and execution of lipotoxic ER stress in pancreatic β-cells publication-title: J Cell Sci doi: 10.1242/jcs.026062 – volume: 32 start-page: 1577 year: 2012 end-page: 1584 ident: CR38 article-title: Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.112.251538 – volume: 56 start-page: 2356 year: 2007 end-page: 2370 ident: CR4 article-title: Increased number of islet-associated macrophages in type 2 diabetes publication-title: Diabetes doi: 10.2337/db06-1650 – volume: 16 start-page: 265 year: 2012 end-page: 273 ident: CR7 article-title: Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome publication-title: Cell Metab doi: 10.1016/j.cmet.2012.07.005 – volume: 17 start-page: 179 year: 2011 end-page: 188 ident: CR21 article-title: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance publication-title: Nat Med doi: 10.1038/nm.2279 – volume: 291 start-page: 3019 year: 2016 end-page: 3029 ident: CR22 article-title: Sustained action of ceramide on the insulin signaling pathway in muscle cells: implication of the double-stranded RNA-activated protein kinase publication-title: J Biol Chem doi: 10.1074/jbc.M115.686949 – volume: 52 start-page: 636 year: 2009 end-page: 644 ident: CR15 article-title: Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets publication-title: Diabetologia doi: 10.1007/s00125-009-1274-2 – volume: 55 start-page: 204 year: 2012 end-page: 214 ident: CR12 article-title: Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells publication-title: Diabetologia doi: 10.1007/s00125-011-2328-9 – volume: 21 start-page: 3220 year: 2001 end-page: 3233 ident: CR19 article-title: Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6 publication-title: Mol Cell Biol doi: 10.1128/MCB.21.9.3220-3233.2001 – volume: 244 start-page: 211 year: 2016 end-page: 215 ident: CR40 article-title: Saturated fatty acids trigger TLR4-mediated inflammatory response publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.11.015 – volume: 14 start-page: 2611 year: 2016 end-page: 2623 ident: CR34 article-title: Saturated fatty acids engage an IRE1α-dependent pathway to activate the NLRP3 inflammasome in myeloid cells publication-title: Cell Rep doi: 10.1016/j.celrep.2016.02.053 – volume: 98 start-page: 615 year: 2015 end-page: 622 ident: CR35 article-title: Altered immunometabolism at the interface of increased endoplasmic reticulum (ER) stress in patients with type 2 diabetes publication-title: J Leukoc Biol doi: 10.1189/jlb.3A1214-609R – volume: 50 start-page: 752 year: 2007 end-page: 763 ident: CR26 article-title: Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-006-0590-z – volume: 140 start-page: 900 year: 2010 end-page: 917 ident: CR31 article-title: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease publication-title: Cell doi: 10.1016/j.cell.2010.02.034 – volume: 15 start-page: 585 year: 2012 end-page: 594 ident: CR42 article-title: A ceramide-centric view of insulin resistance publication-title: Cell Metab doi: 10.1016/j.cmet.2012.04.002 – volume: 28 start-page: 1211 year: 2014 end-page: 1220 ident: CR10 article-title: Minireview: thioredoxin-interacting protein: regulation and function in the pancreatic β-cell publication-title: Mol Endocrinol doi: 10.1210/me.2014-1095 – volume: 280 start-page: 847 year: 2005 end-page: 851 ident: CR29 article-title: Involvement of endoplasmic reticulum stress in insulin resistance and diabetes publication-title: J Biol Chem doi: 10.1074/jbc.M411860200 – volume: 16 start-page: 250 year: 2012 end-page: 264 ident: CR6 article-title: IRE1α Induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress publication-title: Cell Metab doi: 10.1016/j.cmet.2012.07.007 – volume: 274 start-page: 21645 year: 1999 end-page: 21650 ident: CR9 article-title: Identification of thioredoxin-binding protein-2/vitamin D up-regulated protein 1 as a negative regulator of thioredoxin function and expression publication-title: J Biol Chem doi: 10.1074/jbc.274.31.21645 – volume: 15 start-page: 1383 year: 2009 end-page: 1391 ident: CR33 article-title: Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis publication-title: Nat Med doi: 10.1038/nm.2067 – volume: 7 start-page: 854 year: 2014 end-page: 863 ident: CR44 article-title: human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death. Circ-Cardiovasc publication-title: Gene – volume: 92 start-page: 166 year: 2007 end-page: 171 ident: CR43 article-title: Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1518 – volume: 286 start-page: 42446 year: 2011 end-page: 42458 ident: CR23 article-title: Alteration of ceramide synthase 6/C-16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca and ER/Golgi membrane network publication-title: J Biol Chem doi: 10.1074/jbc.M111.287383 – volume: 62 start-page: 401 year: 2013 end-page: 410 ident: CR24 article-title: Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance publication-title: Diabetes doi: 10.2337/db12-0686 – volume: 5 start-page: 781 year: 2003 end-page: 792 ident: CR32 article-title: The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages publication-title: Nat Cell Biol doi: 10.1038/ncb1035 – volume: 107 start-page: 881 year: 2001 end-page: 891 ident: CR20 article-title: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor publication-title: Cell doi: 10.1016/S0092-8674(01)00611-0 – volume: 145 start-page: 5087 year: 2004 end-page: 5096 ident: CR28 article-title: Free fatty acids and Cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappa B and endoplasmic reticulum stress publication-title: Endocrinology doi: 10.1210/en.2004-0478 – volume: 105 start-page: 6912 year: 2008 end-page: 6917 ident: CR16 article-title: Glucose sensing by MondoA : Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0712199105 – volume: 194 start-page: 3917 year: 2015 end-page: 3923 ident: CR2 article-title: Profiling of the three circulating monocyte subpopulations in human obesity publication-title: J Immunol doi: 10.4049/jimmunol.1402655 – volume: 119 start-page: 1201 year: 2009 end-page: 1215 ident: CR11 article-title: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice publication-title: J Clin Invest doi: 10.1172/JCI37007 – volume: 291 start-page: 16328 year: 2016 end-page: 16338 ident: CR13 article-title: Short term palmitate supply impairs intestinal insulin signaling via ceramide production publication-title: J Biol Chem doi: 10.1074/jbc.M115.709626 – volume: 285 start-page: 38568 year: 2010 end-page: 38579 ident: CR41 article-title: Kdo -Lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy publication-title: J Biol Chem doi: 10.1074/jbc.M110.170621 – volume: 11 start-page: 98 year: 2011 end-page: 107 ident: CR3 article-title: Type 2 diabetes as an inflammatory disease publication-title: Nat Rev Immunol doi: 10.1038/nri2925 – volume: 41 start-page: 1012 year: 2016 end-page: 1021 ident: CR5 article-title: Mechanism and regulation of NLRP3 inflammasome activation publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2016.09.002 – volume: 115 start-page: 1111 year: 2005 end-page: 1119 ident: CR25 article-title: Inflammation, stress, and diabetes publication-title: J Clin Invest doi: 10.1172/JCI25102 – volume: 18 start-page: 363 year: 2012 end-page: 374 ident: CR1 article-title: The cellular and signaling networks linking the immune system and metabolism in disease publication-title: Nat Med doi: 10.1038/nm.2627 – volume: 4 start-page: 868 year: 2007 end-page: 879 ident: CR14 article-title: TXNIP regulates peripheral glucose metabolism in humans publication-title: PLoS Med doi: 10.1371/journal.pmed.0040158 – volume: 32 start-page: 1577 year: 2012 ident: 4462_CR38 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.112.251538 – volume: 92 start-page: 166 year: 2007 ident: 4462_CR43 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1518 – volume: 56 start-page: 2356 year: 2007 ident: 4462_CR4 publication-title: Diabetes doi: 10.2337/db06-1650 – volume: 43 start-page: 451 year: 2015 ident: 4462_CR36 publication-title: Immunity doi: 10.1016/j.immuni.2015.08.008 – volume: 16 start-page: 250 year: 2012 ident: 4462_CR6 publication-title: Cell Metab doi: 10.1016/j.cmet.2012.07.007 – volume: 105 start-page: 6912 year: 2008 ident: 4462_CR16 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0712199105 – volume: 8 start-page: 829 year: 2013 ident: 4462_CR17 publication-title: Mol Med Rep doi: 10.3892/mmr.2013.1582 – volume: 17 start-page: 179 year: 2011 ident: 4462_CR21 publication-title: Nat Med doi: 10.1038/nm.2279 – volume: 291 start-page: 16328 year: 2016 ident: 4462_CR13 publication-title: J Biol Chem doi: 10.1074/jbc.M115.709626 – volume: 285 start-page: 38568 year: 2010 ident: 4462_CR41 publication-title: J Biol Chem doi: 10.1074/jbc.M110.170621 – volume: 11 start-page: 136 year: 2010 ident: 4462_CR8 publication-title: Nat Immunol doi: 10.1038/ni.1831 – volume: 280 start-page: 847 year: 2005 ident: 4462_CR29 publication-title: J Biol Chem doi: 10.1074/jbc.M411860200 – volume: 119 start-page: 1201 year: 2009 ident: 4462_CR11 publication-title: J Clin Invest doi: 10.1172/JCI37007 – volume: 15 start-page: 1383 year: 2009 ident: 4462_CR33 publication-title: Nat Med doi: 10.1038/nm.2067 – volume: 18 start-page: 363 year: 2012 ident: 4462_CR1 publication-title: Nat Med doi: 10.1038/nm.2627 – volume: 22 start-page: 950 year: 2014 ident: 4462_CR45 publication-title: Obesity doi: 10.1002/oby.20598 – volume: 28 start-page: 1211 year: 2014 ident: 4462_CR10 publication-title: Mol Endocrinol doi: 10.1210/me.2014-1095 – volume: 62 start-page: 401 year: 2013 ident: 4462_CR24 publication-title: Diabetes doi: 10.2337/db12-0686 – volume: 52 start-page: 636 year: 2009 ident: 4462_CR15 publication-title: Diabetologia doi: 10.1007/s00125-009-1274-2 – volume: 22 start-page: 848 year: 2015 ident: 4462_CR37 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2014.5868 – volume: 291 start-page: 3019 year: 2016 ident: 4462_CR22 publication-title: J Biol Chem doi: 10.1074/jbc.M115.686949 – volume: 274 start-page: 21645 year: 1999 ident: 4462_CR9 publication-title: J Biol Chem doi: 10.1074/jbc.274.31.21645 – volume: 14 start-page: 2611 year: 2016 ident: 4462_CR34 publication-title: Cell Rep doi: 10.1016/j.celrep.2016.02.053 – volume: 4 start-page: 868 year: 2007 ident: 4462_CR14 publication-title: PLoS Med doi: 10.1371/journal.pmed.0040158 – volume: 107 start-page: 881 year: 2001 ident: 4462_CR20 publication-title: Cell doi: 10.1016/S0092-8674(01)00611-0 – volume: 313 start-page: 1137 year: 2006 ident: 4462_CR30 publication-title: Science doi: 10.1126/science.1128294 – volume: 98 start-page: 615 year: 2015 ident: 4462_CR35 publication-title: J Leukoc Biol doi: 10.1189/jlb.3A1214-609R – volume: 244 start-page: 211 year: 2016 ident: 4462_CR40 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.11.015 – volume: 21 start-page: 3220 year: 2001 ident: 4462_CR19 publication-title: Mol Cell Biol doi: 10.1128/MCB.21.9.3220-3233.2001 – volume: 145 start-page: 5087 year: 2004 ident: 4462_CR28 publication-title: Endocrinology doi: 10.1210/en.2004-0478 – volume: 5 start-page: 781 year: 2003 ident: 4462_CR32 publication-title: Nat Cell Biol doi: 10.1038/ncb1035 – volume: 286 start-page: 16596 year: 2011 ident: 4462_CR39 publication-title: J Biol Chem doi: 10.1074/jbc.M110.186916 – volume: 140 start-page: 900 year: 2010 ident: 4462_CR31 publication-title: Cell doi: 10.1016/j.cell.2010.02.034 – volume: 23 start-page: 7448 year: 2003 ident: 4462_CR18 publication-title: Mol Cell Biol doi: 10.1128/MCB.23.21.7448-7459.2003 – volume: 50 start-page: 752 year: 2007 ident: 4462_CR26 publication-title: Diabetologia doi: 10.1007/s00125-006-0590-z – volume: 15 start-page: 585 year: 2012 ident: 4462_CR42 publication-title: Cell Metab doi: 10.1016/j.cmet.2012.04.002 – volume: 286 start-page: 42446 year: 2011 ident: 4462_CR23 publication-title: J Biol Chem doi: 10.1074/jbc.M111.287383 – volume: 16 start-page: 265 year: 2012 ident: 4462_CR7 publication-title: Cell Metab doi: 10.1016/j.cmet.2012.07.005 – volume: 115 start-page: 1111 year: 2005 ident: 4462_CR25 publication-title: J Clin Invest doi: 10.1172/JCI25102 – volume: 7 start-page: 854 year: 2014 ident: 4462_CR44 publication-title: Gene – volume: 194 start-page: 3917 year: 2015 ident: 4462_CR2 publication-title: J Immunol doi: 10.4049/jimmunol.1402655 – volume: 55 start-page: 204 year: 2012 ident: 4462_CR12 publication-title: Diabetologia doi: 10.1007/s00125-011-2328-9 – volume: 11 start-page: 98 year: 2011 ident: 4462_CR3 publication-title: Nat Rev Immunol doi: 10.1038/nri2925 – volume: 121 start-page: 2308 year: 2008 ident: 4462_CR27 publication-title: J Cell Sci doi: 10.1242/jcs.026062 – volume: 41 start-page: 1012 year: 2016 ident: 4462_CR5 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2016.09.002 – reference: 18559892 - J Cell Sci. 2008 Jul 15;121(Pt 14):2308-18 – reference: 20876532 - J Biol Chem. 2010 Dec 3;285(49):38568-79 – reference: 20023662 - Nat Immunol. 2010 Feb;11(2):136-40 – reference: 22013072 - J Biol Chem. 2011 Dec 9;286(49):42446-58 – reference: 21217695 - Nat Med. 2011 Feb;17 (2):179-88 – reference: 22580896 - Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1577-84 – reference: 25602171 - Antioxid Redox Signal. 2015 Apr 1;22(10 ):848-70 – reference: 22560211 - Cell Metab. 2012 May 2;15(5):585-94 – reference: 25363705 - Circ Cardiovasc Genet. 2014 Dec;7(6):854-863 – reference: 27669650 - Trends Biochem Sci. 2016 Dec;41(12 ):1012-1021 – reference: 14559994 - Mol Cell Biol. 2003 Nov;23 (21):7448-59 – reference: 15509553 - J Biol Chem. 2005 Jan 7;280(1):847-51 – reference: 15864338 - J Clin Invest. 2005 May;115(5):1111-9 – reference: 17062758 - J Clin Endocrinol Metab. 2007 Jan;92(1):166-71 – reference: 12907943 - Nat Cell Biol. 2003 Sep;5(9):781-92 – reference: 22883234 - Cell Metab. 2012 Aug 8;16(2):265-73 – reference: 27255710 - J Biol Chem. 2016 Jul 29;291(31):16328-38 – reference: 21454530 - J Biol Chem. 2011 May 13;286(19):16596-605 – reference: 23846350 - Mol Med Rep. 2013 Sep;8(3):829-36 – reference: 17268797 - Diabetologia. 2007 Apr;50(4):752-63 – reference: 19966778 - Nat Med. 2009 Dec;15(12):1383-91 – reference: 19363290 - J Clin Invest. 2009 May;119(5):1201-15 – reference: 20303879 - Cell. 2010 Mar 19;140(6):900-17 – reference: 26687466 - Atherosclerosis. 2016 Jan;244:211-5 – reference: 24911120 - Mol Endocrinol. 2014 Aug;28(8):1211-20 – reference: 10419473 - J Biol Chem. 1999 Jul 30;274(31):21645-50 – reference: 21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107 – reference: 26123743 - J Leukoc Biol. 2015 Oct;98(4):615-22 – reference: 23929697 - Obesity (Silver Spring). 2014 Mar;22(3):950-6 – reference: 18458340 - Proc Natl Acad Sci U S A. 2008 May 13;105(19):6912-7 – reference: 16931765 - Science. 2006 Aug 25;313(5790):1137-40 – reference: 22883233 - Cell Metab. 2012 Aug 8;16(2):250-64 – reference: 26971994 - Cell Rep. 2016 Mar 22;14 (11):2611-23 – reference: 26341399 - Immunity. 2015 Sep 15;43(3):451-62 – reference: 17472435 - PLoS Med. 2007 May;4(5):e158 – reference: 19214472 - Diabetologia. 2009 Apr;52(4):636-44 – reference: 15297438 - Endocrinology. 2004 Nov;145(11):5087-96 – reference: 17579207 - Diabetes. 2007 Sep;56(9):2356-70 – reference: 11779464 - Cell. 2001 Dec 28;107(7):881-91 – reference: 26698173 - J Biol Chem. 2016 Feb 5;291(6):3019-29 – reference: 22006247 - Diabetologia. 2012 Jan;55(1):204-14 – reference: 11287625 - Mol Cell Biol. 2001 May;21(9):3220-33 – reference: 25786686 - J Immunol. 2015 Apr 15;194(8):3917-23 – reference: 22395709 - Nat Med. 2012 Mar 06;18(3):363-74 – reference: 23139352 - Diabetes. 2013 Feb;62(2):401-10
SSID	ssj0003546
Score	2.558333
Snippet	Aims/hypothesis Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the... Obesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the thioredoxin... Aims/hypothesisObesity and type 2 diabetes are concomitant with low-grade inflammation affecting insulin sensitivity and insulin secretion. Recently, the...
SourceID	hal proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	399
SubjectTerms	Body fat Carbohydrates Cellular Biology Ceramide Chemokines Cytokines Desaturase Diabetes Diabetes mellitus Endocrinology Endoplasmic reticulum Enzymes Ethics Glucose Human Physiology IL-1β Inflammasomes Inflammation Insulin Insulin resistance Internal Medicine Kinases Leukocytes (mononuclear) Life Sciences Ligands Lipid metabolism Lipids Macrophages Medicine Medicine & Public Health Metabolic Diseases Monocytes Palmitic acid Peripheral blood mononuclear cells Plasma Protein folding Proteins Pyrin protein Reverse transcription Sphingomyelin Thioredoxin Transcription factors
SummonAdditionalLinks	– databaseName: SpringerLink Contemporary (1997 - Present) dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9RAcOiHSF-0ftVoK6v4pAaSS_Yjj6W0tFCPUmu5t7C3O4sFyUlzLeKvdybZhEqrYB-TTDab2ZmdmZ0vgPeWzYwsuLRUIecWZhnxnJRphqycO1moLuT__FhPp2Y2q05iHnc7RLsPLslupx6T3Vgyc6CZTsmEIQtqFdZJ2hnmxtMv5-P2W8TsHIJOc6NmgyvzriH-EEar3zgU8raeectH2omeg8f3mvQmPIqaptjtSeMJrGDzFB5-jr70Z_CL21Z7cSPTTZB9Tivdiv1T0eeQfBJns-nRicCfMV62EbbxBBeIkPqkR7oQF5xkgoKdAK1YBB4nZnm1gg96BR_0iokYDnqfw9eD_bO9wzR2YkhdWVbLNEdfYUBdWauruVKVCgalMdZrUif8ZJ5LF4zVjjbL0mcKnQ3SS-szZzWSBvIC1ppFgy9BeFkimXgcWjsppfdmboJ3TqFFbXCiE8iGJaldLFPO3TK-12OB5Q6nNeG0ZpzWMoEP4ys_-hod_wJ-R-s8wnF17cPd45rvsReaNNLiOk9geyCDOvJ0W-eVIfuN9OcsgbfjY-JGxq5tcHHFMOxIlUVJ_7HVk8_4KTJtjSlKlcDHgVZuDP63-b76L-jXsEEanenDyrdhbXl5hTvwwF0vL9rLNx2j_AYBEAtJ priority: 102 providerName: Springer Nature
Title	Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes
URI	https://link.springer.com/article/10.1007/s00125-017-4462-5 https://www.ncbi.nlm.nih.gov/pubmed/28988346 https://www.proquest.com/docview/1982175070 https://www.proquest.com/docview/1949085347 https://hal.science/hal-02450833
Volume	61
WOSCitedRecordID	wos000419011600015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1432-0428 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED-tME28jH0vg1XetKdtEc6HY-dpYqiISayqOobyFrm2oyFNKZCCEH_97hInMKHxspdITt3E7fnOv_sG-KBJzeCVCdOsiqiFGUeeEyLkjsC5EUnWhvwfH8rpVBVFPvMGt8aHVfYysRXUdmnIRr6DyjGiZ0Qv_MvpWUhdo8i76ltojGA9inlKjKn2bkI8Ep-og0I4jFRW9F5N3hYRxaM9JBmNChHqY3-dS6NfFBV5F3LecZe2p9D-5v-u_wk89viT7XYb5ik8cPUzePTde9ifwzU1s7bsVv4bQ60d6d-wyZx1mSWf2VEx_TZj7spH0dZM1xbnVbi9ulRIHLATSj1xjFwDDVtW9Byf-9UwMv8yMv-ymPXm3xfwc39ytHcQ-v4MoUnTfBVGzuaucjLXWuaLLMuzSjmhlLYSQYaNF5EwldLSoAhNLc-c0ZWwQltutHSIS17CWr2s3WtgVqQOFT8KuI1TYa1aqMoakzntpHKxDID31CmNL15OPTR-l0PZ5ZagJRK0JIKWIoCPw1dOu8od901-jyQf5lHN7YPdw5LukW8acWpyGQWw3ZO29JzelDd0DeDd8DHyKP27unbLC5pD7lWRpPg7XnU7aXgVKrxKJWkWwKd-a916-L_W--b-pWzBBgI71UWXb8Pa6vzCvYWH5nJ10pyPYSQL2V7VuGWYMax_nUxncxzNfxz_AcuKGiE
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3oVAAYPgAkTkZcc5IFSVVrvqdlWhBe3NeP0QK6Fsabbl8aP4jczk1aKK3nrgmMRxbOeb8YznBfBck5oReRNmwsdUwixCmuM8jBwJ54anonb5_zTKx2M5nRb7K_C7i4Uht8qOJ9aM2i4MnZG_QeUYpWeUXqJ3B99CqhpF1tWuhEYDi1338zuqbNXb4Xv8vy-SZGd7sjUI26oCocmyYhnGzhbOu7zQOi9mQhTCS8el1DbHrdEms5gbL3VukPAzGwlntOeWaxsZnbuEEh0gy79MmexI2ZNbJy4laRsYhEw_jKWYdlbUqE5aiqJESHsCKmCo__21D176Ql6YZ0XcM-bZetfbufG_rddNuN7K12yzIYhbsOLK23B1r_UguAO_qFi3Zafi-9i8tIjvim1_YE3kzGs2mY6H-8z9aL2ES6ZLi-08kk8T6okXbE6hNY6R6aNiC0_9tLFtFaPjbUbH2yxh3fH2Xfh4ITNfh9VyUbr7wCzPHCq25FCcZNxaOZPeGiOcdrl0SR5A1KFBmTY5O9UI-ar6tNI1gBQCSBGAFA_gZf_KQZOZ5LzGzxBifTvKKT7YHCm6R7Z3lMPT4ziAjQ5KquVklTrBUQBP-8fIg2h1dekWR9SGzMc8zXAe9xrk9p9ChV7KNBMBvOqgfKrzf433wflDeQJrg8neSI2G492HcA2FWNl40m_A6vLwyD2CK-Z4Oa8OH9cEyuDzRSP8D1tFdwY
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEC2FgCIu7IshQIPgQrDirRcfEIqSjDLKMBqhgOZmenoRIyFPiCdh-TS-jipvCYrILQeOttv761q6XlUBvNTkZkTehJnwMbUwi3DOcR5Gjoxzw1NRU_4_jeR4rKbTfLICv7tcGKJVdjKxFtR2YWiNfBOdY7Se0XqJNn1Li5jsDN4dfgupgxRFWrt2Gg1E9t3P7-i-VW-HO_ivXyXJYPdgey9sOwyEJsvyZRg7mzvvZK61zGdC5MIrx5XSVqKatMks5sYrLQ0KgcxGwhntueXaRkZLl1DRAxT_V2WKKKYs9e1TeknaJgmhAghjJaZdRDWqC5iiWRGSfkBnDH3Bv3TilS_EyDxv7p4L1dYacHDzf_52t-BGa3ezrWai3IYVV96Btfcts-Au_KIm3padyftj89Ii7iu2-4E1GTVv2MF0PJww96NlD5dMlxbHeZxWTQoobrA5pdw4RiGRii08XafNeasYLXszWvZmCeuWve_Bx0t58_uwWi5K9xCY5ZlDh5eIxknGrVUz5a0xwmknlUtkAFGHjMK0Rdupd8jXoi83XYOpQDAVBKaCB_C6P-WwqVhy0eAXCLd-HNUa39saFbSPYvJon6cncQDrHayKVsJVxSmmAnjeH0bZRF9Xl25xTGMorMzTDN_jQYPi_lbo6CuVZiKAjQ7WZy7-r-d9dPGjPIM1BHYxGo73H8N1tG1VQ7Bfh9Xl0bF7AtfMyXJeHT2t5yqDz5cN8D8WEX_L
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lipid+environment+induces+ER+stress%2C+TXNIP+expression+and+inflammation+in+immune+cells+of+individuals+with+type+2+diabetes&rft.jtitle=Diabetologia&rft.au=Szpigel%2C+Ana%C3%AFs&rft.au=Hainault%2C+Isabelle&rft.au=Carlier%2C+Aur%C3%A9lie&rft.au=Venteclef%2C+Nicolas&rft.date=2018-02-01&rft.pub=Springer+Nature+B.V&rft.issn=0012-186X&rft.eissn=1432-0428&rft.volume=61&rft.issue=2&rft.spage=399&rft.epage=412&rft_id=info:doi/10.1007%2Fs00125-017-4462-5&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-186X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-186X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-186X&client=summon